INTRODUCTION
============

During exocytosis, an evolutionarily conserved molecular machinery regulates transport vesicle targeting, tethering, and fusion at the plasma membrane. In the yeast Saccharomyces cerevisiae this machinery involves the action of the exocyst tethering complex, a Rab family small GTPase Sec4p, and the Sec1/Munc-18 (SM) family protein Sec1p ([@B37]; [@B50]; [@B22]). After tethering and docking, fusion of transport vesicles with the plasma membrane is mediated by the exocytic SNARE (soluble *N*-ethylmaleimide--sensitive factor attachment protein) complex composed of Snc1p/2p, Sec9p, and Sso1p/2p proteins ([@B25]). Despite numerous studies, the molecular interactions and how transport vesicle docking proceeds to SNARE complex--mediated membrane fusion are largely unknown.

The SM protein family members are central regulators of SNARE complex function ([@B16]; [@B29]; [@B50]). They appear to use three apparently different binding modes with the SNARE family proteins ([@B50]). First, several SM family members interact with their cognate SNARE complexes through binding to a N-terminal peptide of syntaxins ([@B4]; [@B14]; [@B53]; [@B40]; [@B32]; [@B8]; [@B50]; [@B24]). Second, the S. cerevisiae Sec1p seems to interact predominantly with an assembled ternary SNARE complex ([@B9]; [@B44]; [@B49]). Third, Munc18-1 and Vps45 bind closed conformations of syntaxin1 or Tlg2p, respectively ([@B34]; [@B15]). However, recent results imply that Munc18-1 also can interact with a ternary SNARE complex and, at the same time, bind the N-terminal peptide of syntaxin1 ([@B13]; [@B45]; [@B12]). In contrast to syntaxins that are involved in exocytosis in higher eukaryotes, yeast Sso1p and Sso2p do not possess a N-terminal peptide. Thus, exocytic Sso protein--containing SNARE complexes may need the contribution of additional components for their efficient assembly and function in vivo. Candidates for such regulators could be SM protein interacting proteins.

In addition to syntaxins, only a few SM-binding proteins are known and, to large extent, detailed understanding on their interaction with SM proteins is lacking. Mint1, Mint2, Doc2, Granulophilin/Slp4, and phospholipase D proteins interact with Munc18-1 in mammalian cells ([@B38]; [@B51]; [@B33]). In yeast, two direct SM family protein interactors, Mso1p and Vac1p, have been identified. Vac1p is a phosphatidyl-inositol-3-phosphate--binding protein that interacts with Vps45p and is required for proper vacuole maintenance ([@B52]). The Sec1p-interacting protein Mso1p was identified as a multicopy suppressor for the *sec1-1* temperature-sensitive mutant ([@B1]). Deletion of *MSO1* in vegetatively growing haploid cells leads to vesicle accumulation at the site of cell growth and completely inhibits fusion of precursor vesicles in the de novo plasma membrane (prospore membrane) formation in sporulating diploid cells ([@B1]; [@B27]; [@B31]). These results suggest a positive role for Mso1p in membrane fusion. Mso1p binds Sec1p with a N-terminal peptide and it copurifies with Sec1p, Ssop/Sec9p/Sncp SNARE complexes, and Sec15p ([@B31]; [@B10]). When combined with conditional mutations in *SEC1*, *SEC2* and *SEC4*, *MSO1* deletion is lethal ([@B1]; [@B31]). Thus, genetic and biochemical interactions position Mso1p functionally in the interface of the exocyst, Sec4p, and SNARE complexes ([@B31]).

To understand how Mso1p and Sec1p interact to regulate membrane fusion, we generated a collection of *sec1* mutants and analyzed their interactions with Mso1p and their functionality in vivo. Our studies show that the putative syntaxin N-peptide binding area in Sec1p domain 1 is important for Mso1p binding. Furthermore, our results indicate that Mso1p can interact with Sso1p and Sso2p. Collectively, the results suggest that Mso1p, through its binding to Sec1p domain 1, stabilizes Sec1p interaction with the SNARE complexes and facilitates membrane fusion.

MATERIALS AND METHODS
=====================

Strains
-------

The yeast strains used are shown in [Table 1](#T1){ref-type="table"}. Standard growth media were used ([@B46]). H3325, H3327, H3329, and H3331 were obtained by mating H2659 with H305, H306, H1127, and H1128 followed by tetrad dissection. Construction of H3476 and H3479 was achieved by transformation of H2905 with wt *SEC1* containing plasmid B578, followed by tetrad dissection to obtain a haploid strain where the sole copy of *SEC1* is expressed from a *URA3* marker containing plasmid. To generate H3582 and H3584, *MSO1* was hemagglutinin (HA)-tagged in H3476 and H3479 by transformation with a PCR cassette generated using pYM24 (B2966) as the template ([@B26]). The *LEU2* plasmids bearing the *sec1* insertion, or point mutations, were transformed into H3582, followed by 5-fluoroorotic acid (5-FOA) treatment to evict the wt *SEC1* in the *URA3* plasmid. *MSO1* was subsequently deleted in these strains by transformation with a PCR cassette generated using pFA6-natNT2 (B3022) as the template ([@B26]).

###### 

Yeast strains

  Name    Genotype                                                                                                                    Source
  ------- --------------------------------------------------------------------------------------------------------------------------- --------------
  H304    *MAT***a***leu2-3,112 ura3-52*                                                                                              P. Novick
  H305    *MAT***a***sec1-1 ura3-52*                                                                                                  P. Novick
  H306    *MAT***a***sec1-11 ura3-52*                                                                                                 P. Novick
  H758    *MAT*α *sec6-4 leu2-3,112 ura3-52*                                                                                          P. Novick
  H759    *MAT***a***sec9-4 leu2-3,112 ura3-52*                                                                                       P. Novick
  H761    *MAT***a***sec15-1 leu2-3,112 ura3-52*                                                                                      P. Novick
  H891    *MAT*α *sec18-1 leu2-3,112 trp1-289 ura3-52*                                                                                R. Schekmann
  H1127   *MAT*α *sec2-41 leu2-3,112 ura3-52*                                                                                         P. Novick
  H1128   *MAT*α *sec4-8 leu2-3,112 ura3-52*                                                                                          P. Novick
  H1152   *MAT***a***sso2-1 leu2-3,112 trp1-1 ura3-1 sso1::HIS3 ade2-1 his3-11,15 can1-100*                                           H. Ronne
  H1910   *MAT***a***ura3 trp1 his3 6lexAop-LEU2*                                                                                     E. Golemis
  H2530   *MAT***a***/MAT*α *leu2-3,112/leu2-3,112 ura3-52/ura3-52*                                                                   This study
  H2598   *MAT***a***lys2 ura3 HO::hisG*                                                                                              M. Knop
  H2599   *MAT*α *lys2 ura3 LEU2::hisG HO::LYS2*                                                                                      M. Knop
  H2657   *MAT***a***leu2-3,112 ura3-52 mso1::MSO1-3HA::kanMX6*                                                                       [@B31]
  H2658   *MAT***a***leu2-3,112 ura3-52 mso1::hphMX4 GAL*+                                                                            [@B31]
  H2659   *MAT*α *ura3-52 his4-619 mso1::MSO1-3HA::kanMX6*                                                                            [@B31]
  H2905   *MAT***a***/MAT*α *his3*Δ*1/his3*Δ*1 leu2*Δ*0/leu2*Δ*0 met15*Δ*0/MET15 LYS2/lys2*Δ*0 ura3*Δ*0/ura3*Δ*0 sec1::kanMX4/SEC1*   EUROSCARF
  H3325   *MAT***a***sec1-1 ura3-52 His4-619 mso1::MSO1-3HA::KanMX6*                                                                  This study
  H3327   *MAT***a***sec1-11 ura3-52 His4-619 mso1::MSO1--3HA::KanMX6*                                                                This study
  H3329   *MAT***a***sec2-41leu2-3 ura3-52 mso1::MSO1-3HA::KanMX6*                                                                    This study
  H3331   *MAT***a***sec4-8 leu2-3,112 ura3-52 mso1::MSO1-3HA::KanMX6*                                                                This study
  H3366   *MAT***a***ura3-52 lys2-801 trp1del63 his3del200 leu2del1 SEC1::SEC1-3HA-kanMX*                                             M. Knop
  H3367   *MAT***a***ura3-52 lys2-801 trp1del63 his3del200 leu2del1 mso1del::hphMX SEC1::SEC1-3HA-kanMX*                              M. Knop
  H3419   *MAT*α *his3-del200 leu2-3,112 ura3-52 ABP1-RFP::HIS3*                                                                      D. Drubin
  H3463   *MAT***a***LSP1::LSP1-RFP-KanMX leu2-3,112 ura3-52*                                                                         This study
  H3466   *MAT***a***LSP1::LSP1-RFP-KanMX pil1::natNT2 leu2-3,112 ura3-52*                                                            This study
  H3476   *MAT***a***his3*Δ*1 leu2*Δ*0 lys2*Δ*0 ura3*Δ*0 sec1::kanMX4* \[*YCpSEC1-URA3*\]                                             This study
  H3479   *MAT*α *his3*Δ*1 leu2*Δ*0 lys2*Δ*0 ura3*Δ*0 sec1::kanMX4* \[*YCpSEC1-URA3*\]                                                This study
  H3582   *MAT***a***his3*Δ*1 leu2*Δ*0 lys2*Δ*0 ura3*Δ*0 sec1::kanMX4 MSO1::MSO1-3HA-hphMX* \[*YCpSEC1-URA3*\]                        This study
  H3584   *MAT*α *his3*Δ*1 leu2*Δ*0 lys2*Δ*0 ura3*Δ*0 sec1::kanMX4 MSO1::MSO1-3HA-hphMX* \[*YCpSEC1-URA3*\]                           This study

Plasmids
--------

Plasmids used are shown in the Supplementary Table 1. For bimolecular fluorescence complementation (BiFC), PCR-amplified *SEC1* wt or the site-directed mutants were cloned as BamHI/SalI fragments into plasmid B2986. Similarly, *MSO1* was cloned as a BglII/XhoI fragment into p416 METYC-CDC42 (B3031) ([@B11]) by replacing *CDC42* with *MSO1*. The *SEC1* wt and the L25D mutant were ligated to B3021 after releasing them from B2930 and B3060 with BamHI/SalI digestion. As the non-Sec1-binding controls, DNA fragments encoding N-terminal deletants of *MSO1* (amino acids 59-210 or 136-210) were amplified with BglII and XhoI sites and cloned into B3031 to generate B3043 and B3353, respectively. Furthermore, the *MSO1* fragments for amino acids 1-58, and 1-135 were amplified with BglII and XhoI sites and cloned into B3031. For stronger expression, full-length *MSO1* or *MSO1(136-210)* were amplified with SpeI and SalI restriction sites and cloned into B2985 containing an *ADH1* promoter (B2918 and B3012, respectively). To generate B3307, the *SSO1* open reading frame (ORF) was amplified by PCR with BamHI and EcoRI sites and cloned into the BiFC vector B3018. For B3309, the *SSO2* ORF was amplified by PCR with BamHI/BamHI sites and subcloned into B3018.

For the yeast two-hybrid analysis, the fragments encoding cytosolic parts of *SSO1*, *SNC1,* and *SNC2* were amplified by PCR with EcoRI and XhoI restriction sites and cloned into B1226. The *SSO2* was cut out from B1487 with EcoRI and XhoI and ligated into B1226. Sequences encoding Sec1p domain 1 and domain 3B were amplified by PCR with EcoRI and XhoI sites and ligated into B1226, generating B3272 and B3271, respectively. To generate B3400 and 3401, the *MSO1(38-94*) and *MSO1(38-132*) were amplified adding NcoI and XhoI restriction sites and cloned into B1231. For B3364, the *MSO1(136-210)* was amplified adding BglII and XhoI sites and cloned into B1232 that had been linearized with BamHI and XhoI.

For the *SEC1* insertion library, wt *SEC1* was first cloned into pBluescript SK− as a HindIII/XbaI fragments. The plasmid B2856 was generated by site-directed mutagenesis (QuickChange, Stratagene, La Jolla, CA) to introduce StuI and BglII restriction sites before the start codon and after the stop codon in *SEC1*. For the yeast two-hybrid assay, the B3073 plasmid was generated from pB42AD-B by removal of the NotI site with the Klenow enzyme (New England Biolabs, Beverly, MA). The plasmid SEC1pB42AD-BΔNotI (B3074) containing the wt *SEC1* fragment was generated by cloning a StuI and BglII fragment from B2856. For in vivo studies, wt *SEC1*, or the insertion mutant versions, were subcloned into B707 where the NotI restriction site had been removed by filling-in with Klenow enzyme. Point mutations in *SEC1* were introduced by site-directed mutagenesis using plasmid B2856 as the template. The *SEC1* containing the BglII/StuI fragment was cloned into B3072 and B3074 to replace the wt *SEC1*. The sequenced *sec1* insertion mutants were cloned into B3072 as BglII and StuI fragments. All DNA fragments generated by PCR were sequenced.

SEC1 Insertion Library
----------------------

A *SEC1* pentapeptide insertion mutant library was generated using the Mutation Generation System (Finnzymes, Espoo, Finland) that exploits a MuA transposase--catalyzed in vitro transposition reaction and generates five amino acid insertions into proteins ([@B20]; [@B43]). Four standard transposition reactions were performed, each with 500 ng of B2856 as a target and 100 ng of cat-Mu(NotI) as a transposon donor ([@B43]). After incubation at 30°C for 4 h and inactivation at 75°C for 10 min, reactions were pooled, extracted with phenol/chloroform, ethanol-precipitated, and resuspended in water. Approximately 1 × 10^6^ Escherichia coli DH10B transformants were pooled and grown in LB-Ap-Cm medium at 37°C for 2 h. Plasmid DNA from the pool (pJJHS1) was isolated and digested with StuI and BglII, followed by preparative electrophoresis on a 0.8% SeaPlaque GTG (Lonza, Basel, Switzerland) agarose gel in TAE buffer. The 3.2-kb DNA fragment pool, corresponding to transposon insertions into *SEC1*-encoding DNA segment, was isolated by electroelution and ligated into StuI- and BglII-cut B3073, followed by electroporation into DH10B cells. Plasmid DNA was prepared from ∼7 × 10^4^ colonies (pJJHS2). Most of the transposon DNA was then eliminated from the plasmid pool by NotI cutting, followed by agarose gel purification of the plasmid backbone and recircularization by ligation. Ligated plasmids were electroporated into DH10B cells to generate the final *SEC1* insertion mutant library for which DNA was isolated from ∼6 × 10^4^ colonies (pJJHS4).

Yeast Two-Hybrid Assay
----------------------

The yeast two-hybrid assay with the EGY48 (H1910) strain was performed as described previously ([@B17]). The plasmids B1227 (pSH18-34), B1228 (pRFHM1), and B1229 (pSH17-4) were used as positive and negative controls. Four independent transformants were initially examined for growth on SC-Ura-Leu-His-Trp + 1% raffinose + 2% galactose. The blue/white screening was performed on X-gal plates (SD-Ura-His-Trp + 100 mM sodium phosphate (pH 7) + 0.6% glucose + 1.4% galactose + 0.2 mg/ml X-gal). For the *sec1* insertion library screen EGY48 cells were transformed with plasmids B1227 and B1254 and the *sec1* insertion library (pJJHS4). After transformation the cells were regrown in nonselective medium for 4 h and then directly plated on the X-gal plates. Three pools, each containing 150 white, light blue, and blue colonies, were created and the sites of insertions mapped as described previously ([@B39]).

In Vitro Binding Assays
-----------------------

His~6~-tagged Mso1p (amino acids 35-210) was produced in E. coli and purified using Ni-NTA agarose ([@B42]). Glutathione *S*-transferase (GST)-fusion proteins Sso1p (amino acids 1-265) and Sso2p (amino acids 1-269) were purified with glutathione-Sepharose (Amersham, Uppsala, Sweden; [@B27]), followed by thrombin cleavage. Mso1p was immobilized on CM5 biosensor chip (Amersham) using amino-coupling chemistry according to manufacturer\'s instructions. Sso1p and Sso2p were injected in 10 mM HEPES-KOH, 150 mM NaCl, 0.005% surfactant P20, pH 7.4, with flow rate of 40 μl/min for 5 min, followed by a 10-min dissociation time. The results were evaluated by 1:1 Langmuir binding model in Biacore Evaluation Software 3.1. The obtained equilibrium binding level responses are given in resonance units.

Antibodies
----------

The anti-HA (12CA5) was purchased from Roche (Indianapolis, IN) and the myc-tag antibodies (9E10) were obtained from Kristiina Takkinen (VTT Technical Research Center, Otaniemi, Finland). The anti-Sec1p antibody used was the affinity-purified anti-Sec1p (no. 57; [@B44]), from James McNew (Rice University, Houston, TX). Anti-Sec9p-NT antibodies ([@B6]) were obtained from Patrick Brennwald (University of North Carolina at Chapel Hill). Anti-Sso1/2p (K8) and Mso1p (R285) antibodies have been previously described ([@B1]; [@B27]). Dilutions used for Western blotting were 1:2000 anti-HA, 1:5000 anti-Sec1p (no. 57), 1:1000 anti-Sec9p-NT, 1:20000 anti-Sso1p/2p (K8), and 1:2000 anti-Mso1p.

Immunoprecipitations
--------------------

Immunoprecipitations were performed as described previously ([@B31]). For Western blot analysis, proteins were transferred onto nitrocellulose membranes, and the bound antibodies were visualized with the ECL detection system (Pierce, Rockford, IL). Each immunoprecipitation was performed three to five times, quantified using Bio-Rad Quantity One software (Sundbyberg, Sweden) and normalized for the amount of immunoprecipitated Mso1p-HA.

Fluorescence Microscopy
-----------------------

Cells were grown to OD~600~ 0.8-1 at the permissive temperature. The temperature-sensitive cells were shifted to 37°C for 1 h before microscopy with the Olympus Provis microscope with a Plan Apo 60× 1.40 NA oil ph3 objective and bright-field and FITC filters (Olympus, Tokyo, Japan). The software used for recording images was AnalySIS. The exposure time for the bimolecular fluorescence complementation signal was 5--10 s. Images were prepared using Adobe Photoshop7 software (San Jose, CA). Fluorescence intensities of the Mso1p--Sec1p interaction signal in the cytosol of the mother cell were quantified by measuring the volume intensity of equal-sized squares of 50--120 cells with Bio-Rad Quantity One software. BiFC interaction intensities were quantified by measuring the mean gray value of random points on the plasma membrane using ImageJ 1.42 (<http://rsb.info.nih.gov/ij/>). For each condition the signals from at least 50 cells were quantified.

Homology Model of Sec1p
-----------------------

The structures of yeast Sly1p (1mqs) ([@B4]), rat Sec1 (1dn1) ([@B7]), and Munc18c (2pjx) ([@B24]) were retrieved from the RCSB Protein Data Bank, superimposed, and used as templates for the modeling of Sec1p. Prime 1.6 (Schrödinger, Portland, OR) was used to align the Sec1p sequence with the structure-based alignment of the three templates and squid Sec1 (1fvf) ([@B3]). Corrections to this alignment were introduced manually, taking the positions of secondary structure elements in the templates into account. 1dn1 was used as template for residues 1-470 and 586-644, 1mqs for 471-508 and 544-585, and 2pjx for 509-543. The overall sequence identity between Sec1p and the structural templates ranges from 22 to 26%. Major differences between the sequences of Sec1p and the templates are in the C-terminal segments. These areas were omitted from the alignment and model building so that the final structural model of Sec1p consists of amino acids M1 to R643. Prime 1.6 was used to build loops for 27 insertion and deletion regions, and after this, new side chains were placed, and their conformations were optimized.

RESULTS
=======

Mso1p and Sec1 Interact at Sites of Secretion
---------------------------------------------

Mso1p localizes in the bud tip and in the septum of dividing yeast cells ([@B31]; [@B10]). On the other hand, the Mso1p-interacting protein Sec1p and the SNARE proteins Sso1p, Sso2p, and Sec9p localize, in addition to the growing bud, along the mother cell plasma membrane ([@B6]; [@B44]). To evaluate the Mso1p--Sec1p interaction site in vivo, we made use of the BiFC technique ([@B23]; [@B30]; [@B47]). Plasmids for expression of fusion proteins of Mso1p and the C-terminal fragment of yellow fluorescent protein (YFP; YFP(C)-Mso1) and Sec1p and the N-terminal fragment of Venus \[Sec1-Venus(N)\] were transformed to yeast cells followed by analysis of the YFP signal. The in vivo function of these fusion proteins was verified by their ability to rescue mutant phenotypes in the respective genes (data not shown).

In haploid, vegetatively grown cells, the Mso1p--Sec1p interaction site localizes to the bud tip, the growing bud, and the bud neck ([Figure 1](#F1){ref-type="fig"}A, arrowheads). In the growing bud, a dotty signal ([Figure 1](#F1){ref-type="fig"}A, arrows) along the plasma membrane was frequently observed. A similar signal at the plasma membrane was also detected for the Mso1p(1-58) fragment and Sec1p ([Figure 1](#F1){ref-type="fig"}B). The 1-58 fragment contains the minimal Sec1p-binding sequence (amino acids 38-59) of Mso1p ([@B31]). In cells expressing Sec1p-Venus(N) and a mutant version of Mso1p lacking the Sec1p-binding domain \[YFP(C)-Mso1p(59-210) and YFP(C)-Mso1p(136-210)\], negligible YFP signal was observed ([Figure 1](#F1){ref-type="fig"}, A and B). In 32% of the budding cells, Mso1p--Sec1p interaction was also detected in the mother cell plasma membrane on one side of the bud ([Figure 1](#F1){ref-type="fig"}A, star). This signal is likely to correspond to a former or a newly selected bud site that typically localizes axially next to the current bud site in haploid cells. The Mso1p--Sec1p interaction was also analyzed in vegetatively grown diploid cells that follow a bipolar budding mode. Similarly to haploid cells, Mso1p--Sec1p interaction localized to the bud tip, growing bud, and the septum ([Figure 1](#F1){ref-type="fig"}C, arrowheads). In 44% of budding cells, Mso1p--Sec1p interaction was observed on the pole opposite to the growing bud ([Figure 1](#F1){ref-type="fig"}C, star). No signal was detected at the cell poles in diploid cells undergoing cytokinesis ([Figure 1](#F1){ref-type="fig"}C). This indicates that the Mso1p--Sec1p complexes detected by BiFC do not represent terminally plasma membrane locked complexes, but are dynamic by nature.

![Localization of the Mso1p--Sec1p interaction site in vivo. (A) Live cell imaging of vegetatively grown haploid (H304) cells expressing YFP(C)-Mso1p (B3044) or YFP(C)-Mso1p(136-210) (B3064) with Sec1p-Venus(N) (B2930). (B) Live cell imaging of vegetatively grown haploid cells (H304) expressing YFP(C)-Mso1p(1-58) (B3355), YFP(C)-Mso1p(1-135) (B3354), YFP(C)-Mso1p(1-210) (B3044), YFP(C)-Mso1p(59-210) (B3353), or YFP(C)-Mso1p(136-210) (B3064) with Sec1p-Venus(N) (B2930), and (C) diploid (H2530) cells expressing Mso1p-Venus(C) (B2918) or Mso1p(136-210)-Venus(C) (B3012) with Sec1p-Venus(N) (B2930). Mso1p--Sec1p interaction is detected preferentially at the bud tip, plasma membrane of the growing bud, and the bud neck (arrowheads). Regularly, the interaction signal appeared dott-like (arrows). The interaction site was adjacent to the bud or at the opposite pole of the cells (star). (D) Mso1p--Sec1p interaction is altered in different secretion mutants. Indicated mutants cells expressing YFP(C)-Mso1p (B3044) with Sec1p-Venus(N) (B2930) were grown to OD~600~ 0.8--1 at 24°C, split, and either left at 24°C or shifted to 37°C for 1 h before investigation. Mislocalization and clusters of the interaction signal are pointed out by arrows or a dotted line.](zmk0081094150001){#F1}

To identify factors that affect Mso1p--Sec1p interaction, we analyzed the Mso1p--Sec1p BiFC signal in different temperature-sensitive mutants functionally linked to Sec1p. At the permissive temperature 24°C, Mso1p--Sec1p complex localization was similar both in wild-type and in *sec18-1*, *sec9-4*, *sec4-8*, *sec2-41*, *sec15-1,* and *sec6-4* cells ([Figure 1](#F1){ref-type="fig"}D; [Table 2](#T2){ref-type="table"}). In *sec18-1* cells, defective in *cis*-SNARE complex disassembly at the restrictive temperature, Mso1p--Sec1p complexes accumulated in dots ([Figure 1](#F1){ref-type="fig"}D, arrows). The dots could represent accumulations of SNARE complexes. The *sso2-1* Δ*sso1* mutant has an abnormal morphology, with large cells attached to each other because of abnormal cytokinesis ([@B27]). When incubated at the restrictive temperature, the signal for Mso1p--Sec1p interaction throughout the whole plasma membrane became more pronounced, and at the same time, the signal in the septum was reduced ([Figure 1](#F1){ref-type="fig"}D, dotted line, [Table 2](#T2){ref-type="table"}). This suggests a defect in the polarization of Mso1p--Sec1p complexes in these cells. In *sec9-4* cells, the Mso1p--Sec1p interaction signal remained at the septum after a shift to the restrictive temperature. However, a lower signal in the bud and a partial mislocalization throughout the plasma membrane was also observed ([Figure 1](#F1){ref-type="fig"}D, arrows and dotted line; [Table 2](#T2){ref-type="table"}).

###### 

Quantification of Mso1p--Sec1p interaction site in different secretion mutants

  Strains; temperature     Distribution of the Mso1p--Sec1p interaction signal (%)                        
  ------------------------ --------------------------------------------------------- ------ ------ ------ ------
  wt; 24°C                 51.8                                                      11.0   0.0    2.5    34.7
  wt; 37°C                 44.5                                                      8.4    0.0    12.5   34.5
  *sec18-1*; 24°C          48.0                                                      14.0   4.0    0.0    34.0
  *sec18-1*; 37°C          16.2                                                      35.3   11.1   0.0    37.4
  *sso2-1* Δ*sso1*; 24°C   12.5                                                      16.7   47.2   0.0    23.6
  *sso2-1* Δ*sso1*; 37°C   5.8                                                       6.7    58.4   0.8    28.3
  *sec9-4*; 24°C           42.0                                                      21.4   0.0    0.0    36.6
  *sec9-4*; 37°C           8.2                                                       33.7   12.2   2.0    43.9
  *sec4-8*; 24°C           42.9                                                      10.7   0.0    7.1    39.3
  *sec4-8*; 37°C           1.7                                                       8.5    0.0    45.8   44.0
  *sec2-41;* 24°C          37.3                                                      17.6   0.0    7.8    37.3
  *sec2-41*; 37°C          0.0                                                       15.0   0.0    45.0   40.0
  *sec15-1*; 24°C          39.1                                                      15.2   0.0    3.3    42.5
  *sec15-1*; 37°C          16.9                                                      16.9   0.0    6.2    60.0
  *sec6-4*; 24°C           48.3                                                      13.8   0.0    0.0    37.9
  *sec6-4*; 37°C           3.3                                                       13.1   0.0    1.6    82.0

A prominent change in the Mso1p--Sec1p interaction site was observed in *sec4-8* and *sec2-41* cells after 1-h incubation at the restrictive temperature. Mutations in the small GTPase Sec4p abolish coimmunoprecipitation of Mso1p with SNARE complexes, but not with Sec1p ([@B31]). In line with these findings, in *sec4-8* and *sec2-41* cells incubated at the restrictive temperature, the Mso1p--Sec1p complexes no longer accumulated at the sites of secretion in vivo. Instead, compared with cells grown at 24°C, an greater than fivefold increase in fluorescence signal was detected in the cytosol ([Figure 1](#F1){ref-type="fig"}D; [Table 2](#T2){ref-type="table"}). This suggests that Mso1p and Sec1p still can interact, but are not associated with the plasma membrane. This change in distribution may be due to disassembly of SNARE complexes in *sec2-41* and *sec4-8* cells ([@B19]; [@B18]). In the exocyst subunit mutants (*sec15-1*, *sec6-4*), the Mso1p--Sec1p interaction signal at the plasma membrane was reduced at the restrictive temperature, but was not completely abolished ([Figure 1](#F1){ref-type="fig"}D; [Table 2](#T2){ref-type="table"}). Typically, Mso1p--Sec1p interaction signal persisted in the septum during cytokinesis of most of the temperature-sensitive mutants. This suggests slower dynamics for Mso1p--Sec1p complex turnover at that location.

Mso1p Stability Is Dependent on Sec1p
-------------------------------------

Previously, SM family protein Sly1p binding with its interaction partner Ufe1p was shown to protect Ufe1p from degradation ([@B5]). Mso1p and Sec1p are normally found complexed at the plasma membrane ([Figure 1](#F1){ref-type="fig"}A). When plasma membrane association is disrupted, e.g., by the inactivation of Sec4p, the Mso1p--Sec1p complex appears to be stable in the cytosol ([Figure 1](#F1){ref-type="fig"}D). These results, together with the previous biochemical data ([@B31]) indicate that the life cycles of these two proteins are closely coupled. To test whether Mso1p stability is dependent on Sec1p, Mso1p was carboxy-terminally HA-tagged at its own genomic locus in *sec1-1* and *sec1-11* cells, where Sec1p can be functionally inactivated by a temperature shift to 37°C. When the amount of Mso1p-HA and Sec1-1p and Sec1-11p was analyzed by Western blotting in these cells, a clear reduction in Mso1p levels was observed (68 and 65%, respectively; [Figure 2](#F2){ref-type="fig"}A). This suggests that in cells expressing these Sec1p mutants, Mso1p becomes unstable and is degraded. At the same time, the expression levels for Sec1p, Sso1p/2p ([Figure 2](#F2){ref-type="fig"}, A and B), and Sec9p (data not shown) did not change significantly. In wild-type and *sec2-41* and *sec4-8* strains, only a slight change in Mso1p levels was observed (4, 7, and 17% reduction, respectively) at 37°C. On overexpression of wt *SEC1* in *sec1-1* and *sec1-11* cells, Mso1p levels were restored to wild-type levels ([Figure 2](#F2){ref-type="fig"}B). These results underscore the importance of an active Sec1p for Mso1p stability. We next studied a possible effect of Mso1p deletion on Sec1p levels. As shown in [Figure 2](#F2){ref-type="fig"}C, Sec1p levels are not significantly affected by *MSO1* deletion. This result is in line with the nonessential role of Mso1p for vegetative haploid cell growth.

![Mso1p stability is depended on Sec1p. (A) The wild-type, *sec1-1*, *sec1-11*, *sec2-41* and *sec4-8* strains where the sole copy of *MSO1* is HA tagged were grown to an OD~600~ of 1 at 24°C, split, and either maintained at 24°C or shifted to 37°C for 1 h before lysate preparation. Lysates were subjected to Western blotting and detection with anti-HA and anti-Sso1p/2p antibodies. (B) Overexpression of *SEC1* restores Mso1p levels. A *SEC1* overexpression vector or an empty vector was transformed to wild-type and *sec1-1* and *sec1-11* cells expressing Mso1p-HA. The temperature shift experiment was performed as is in (A). Detection was done with anti-HA and anti-Sec1p antibodies. (C) Sec1p level is not affected by *MSO1* deletion. HA-tagged Sec1p was detected in wild-type and Δ*mso1* cells. (A--C) The quantification of the ECL signals, normalized against the wild-type 24°C lysate, are shown underneath each lane.](zmk0081094150002){#F2}

Mapping of Mso1p-binding Site in Sec1p
--------------------------------------

The amino acids 38-59 at the amino terminus of Mso1p are necessary and sufficient for Sec1p binding ([@B31]). However, the Mso1p-binding site in Sec1p is unknown. To study this, we made use of a Mu-transposition--assisted mutagenesis method that results in five amino acid insertions randomly in the target protein ([@B48]; [@B43]; [@B39]). A plasmid library encoding such mutant Sec1 proteins was created and used as a prey in a yeast two-hybrid screen with Mso1p as the bait. Sec1p insertion mutants (n = 1189) were obtained, 6% of which were noninteracting (white colonies), 53% weakly interacting (light blue), and 41% strongly interacting (dark blue) with Mso1p.

The distribution of the insertion sites in *SEC1* was mapped in 150 clones per interaction mode category. Mutations resulting in no interaction with Mso1p were mainly clustered, whereas mutations that allowed interaction with Mso1p (blue and light-blue) were distributed rather evenly throughout the gene ([Figure 3](#F3){ref-type="fig"}A and Supplementary Figure S1). Because of clear differences in percentages of the obtained mutants, it can be assumed that only the noninteracting pool was saturated. The two most pronounced clusters of mutations that weakened the interaction with Mso1p were located at the beginning of domain 2a and at the end of domain 2b ([Figure 3](#F3){ref-type="fig"}A). It is possible that these mutations cause Sec1p misfolding, because crystal structures of Sec1p homologues show that domain 2 is formed by cooperative folding of amino- and carboxy terminal parts of the polypeptide ([@B34]; [@B3]; [@B4]). It is thus possible that these regions do not represent the domain interacting with Mso1p, but that rather the overall folding of Sec1p was impaired. Another cluster of mutations that resulted in white colonies was located at the end of domain 2a, bridging to domain 3. Furthermore, a cluster of noninteracting mutations was localized at the end of domain 3 close to the location of the known *sec1-1* (G443E) and *sec1-11* (R432P) mutations. At the same time, domain 3 contained several insertion mutations that did not affect Mso1p interaction (Supplementary Figure S2, A and B). Several noninteracting mutations also localized at the beginning of the Sec1p C-terminal tail, which bears no homology to other SM proteins. In addition to these mutations, domain 1 contained several noninteracting insertion mutations ([Figure 3](#F3){ref-type="fig"}).

![Mapping of the Mso1p-binding site in Sec1p. (A) Map of the Mso1p interacting (blue), weakly interacting (light blue), and noninteracting (white) *sec1* mutations. The insertion sites are indicated by black vertical lines within the *SEC1* gene. Twenty mutants were sequenced to confirm the mapping. The domain borders of Sec1p are indicated above of the gene. (B) Yeast two-hybrid assay between different Mso1p fragments and Sec1p domains 1 and 3. Mso1p (59-210) is lacking the Sec1p-binding area ([@B31]). As an additional negative control, Bicoid (B1228) and as a positive control Gal4 (B1229) were used. Two 10-fold dilutions of cells were grown with or without leucine.](zmk0081094150003){#F3}

Sec1p domain 1 and domain 3B have a predicted globular structure. Possible interactions of domain 1 and 3 with Mso1p were analyzed directly by the yeast two-hybrid assay ([Figure 3](#F3){ref-type="fig"}B). As a positive control we used Mso1p(38-210), which binds to the full-length Sec1p ([@B31]). The Sec1p domain 1 showed binding to Mso1p, whereas no interaction with Sec1p domain 3B was observed. Negligible interaction between Mso1p(59-210) lacking the previously reported minimal Sec1p-binding area ([@B31]) and Sec1p domain 1 was observed. These results suggest that Mso1p can interact with Sec1p domain 1.

Mso1p Interaction with Sec1p Is Affected by Mutations in the Putative Syntaxin N-Peptide-binding Area
-----------------------------------------------------------------------------------------------------

To better define the Mso1p interaction site, a more precise understanding of the S. cerevisiae Sec1p structure was needed. Therefore, a model of Sec1p structure was created based on the structures of homologues SM family proteins ([Figure 4](#F4){ref-type="fig"}). The model pointed out two potential protein interaction interfaces in domain 1 that correspond to the previously identified N-peptide and syntaxin-binding sites in SM proteins ([Figure 4](#F4){ref-type="fig"}, B--D). When the insertion mutation sites were placed in this model, several mutations that abolished Mso1p--Sec1p interaction, localized in two α-helices adjacent to the hydrophobic pocket, known to be important for syntaxin N-peptide binding in SM proteins (Supplementary Figure S2, A and B).

![A model for Sec1p structure. (A) The overall structure of Sec1p. Two potential protein-binding interfaces can be identified: the putative syntaxin binding and the N-peptide--binding site. (B) A detailed view of domain 1 where the potential N-peptide and syntaxin-like binding sites are located. Helices are depicted in red and strands in light blue. Only side chains of residues that were subjected to site targeted mutagenesis are shown. (C and D) Surface and ribbon presentations of the putative N-peptide-- (C) and syntaxin- (D) binding sites. The Connolly surface is colored green for hydrophobic, red for hydrogen-bonding, and blue for mildly polar atoms. Only positions of residues mutated in the present study are indicated.](zmk0081094150004){#F4}

To test the functionality of the putative N-peptide binding area for Mso1p interaction, mutations Q113A in a residue at the mouth of the potential pocket, F115A in a central conserved pocket residue, and L125D in a conserved pocket-forming residue were generated ([Figure 4](#F4){ref-type="fig"}, B and C). At the same time, double mutants Q113A L125D and F115A L125D were made. Two additional mutations (I111K and Q116A), not predicted to be directly involved in the pocket formation, were also introduced.

When Sec1p proteins with mutations affecting the putative N-peptide--binding area, or residues close by, were assayed in the yeast two-hybrid assay for Mso1p binding, Q113A and Q116A mutants displayed binding with Mso1p that was comparable to that of the wt Sec1p ([Figure 5](#F5){ref-type="fig"}A). At the same time, I111K and F115A mutants showed slightly reduced binding, whereas the L125D mutant clearly affected the association of Sec1p with Mso1p. When Q113A or F115 were combined with the L125D mutation, Sec1p interaction with Mso1p was abolished ([Figure 5](#F5){ref-type="fig"}A).

![Mso1p binding is affected by mutations in the putative N-peptide binding area in Sec1p. (A) Yeast two-hybrid assay between Mso1p and different Sec1p mutants. As a negative control Bicoid (B1228) and as a positive control Gal4 (B1229) were used. Two 10-fold dilutions of cells grown on medium without leucine are shown. (B and C) Mso1p coimmunoprecipitates less efficiently with Sec1p N-peptide domain mutants. Cells with endogenously HA-tagged Mso1p expressing different *sec1* mutants were grown to OD~600~ = 1, lysed, and subjected to anti-HA immunoprecipitations. Immunoprecipitates were subjected to Western blotting and detection with anti-HA, Sec1p, and Sso1p/2p antibodies. (B) A representative Western of the immunoprecipitations. (C) Quantification of independent immunoprecipitation normalized to the amount of immunoprecipitated Mso1p-HA. SDs are shown for each immunoprecipitation. (D) Localization of the Mso1p interaction site with Sec1p mutants L125D, Q113A L125D, and F115 L125D. Haploid vegetatively grown cells (H304) expressing YFP(C)-Mso1p (B3044) and different mutant versions of Sec1p-Venus(N) \[wt (B2930), L125D (B3263), Q113A L125D (B3264), and F115A L125D (B3265)\] were investigated by fluorescence microscopy. The BiFC signal was quantified as described in *Materials and Methods*.](zmk0081094150005){#F5}

We next analyzed coimmunoprecipitation of these mutants with Mso1p-HA (expressed from its own promoter) in strains where the mutant version of Sec1p were the sole copy of Sec1p (expressed from its own promoter). The results show that although Q113A and F115A mutations have little effect (98 ± 9 and 106 ± 9%, respectively) on Mso1p coimmunoprecipitation, the L125D (74 ± 17, 26% less), Q113A L125D (70 ± 15%, 30% less), and F115A L125D (59 ± 7%, 41% less) mutations caused reduced Sec1p binding ([Figure 5](#F5){ref-type="fig"}, B and C). For Sso protein coimmunoprecipitation with Mso1p, the Q113A mutation had no effect (100 ± 28%). However, when compared with wt Sec1p expressing cell lysates, F115A (75 ± 24), L125D (57 ± 23%), Q113A L125D (64 ± 16%), and F115A L125D (45 ± 9%) all caused reduction in Sso protein coimmunoprecipitation with Mso1p ([Figure 5](#F5){ref-type="fig"}, B and C). Western blot analysis showed that the mutant Sec1 proteins were expressed at the wt Sec1p level in these cells (Supplementary Figure S3). This indicates that the reduced coimmunoprecipitation was not due to lower abundance of these proteins in the lysates.

To evaluate the in vivo effect of mutations in the putative N-peptide binding area, the growth of cells expressing these mutants (I111K, Q113A, F115A, Q116A, L125D, Q113A L125D, and F115A L125D) as their sole copy of Sec1p was monitored. In these strains, temperature sensitivity was observed at 38°C for *sec1* (L125D), at 37°C for *sec1* (Q113A L125D), and at 34°C for *sec1* (F115A L125D) (Supplementary Figure S4A). Given that these mutations reduce or abolish Mso1p binding, deletion of Mso1p was not expected to have a significant additive effect in these strains. Indeed, deletion of *MSO1* did not markedly change temperature sensitivity of these strains (Supplementary Figure S4B).

We next subjected Sec1p wt, L125D, and the double mutants Q113L L125D and F115A L125D to BiFC analysis for Mso1p interaction. Compared with the wt Sec1p, L125D mutation caused a 63% weaker signal with Mso1p at the plasma membrane ([Figure 5](#F5){ref-type="fig"}D). This signal was, nevertheless, properly localized in the bud and in the septum of dividing cells. In case of the Q113L L125D and F115A L125D mutants, the BiFC signal for interaction with Mso1p was significantly reduced at the plasma membrane (81 and 96%, respectively) and in the cytosol (59 and 65%, respectively; [Figure 5](#F5){ref-type="fig"}D). These signal intensities match the level of the Sec1p nonbinding control Mso1p(136-210) (data not shown, see [Figure 1](#F1){ref-type="fig"}A). This indicates that these mutations severely affect Mso1p--Sec1p interaction at the plasma membrane in vivo.

Mso1p interaction with Sec1p is required for membrane fusion during sporulation of diploid S. cerevisiae cells ([@B31]). When diploid cells expressing only the mutant version of Sec1p were assayed for their ability to sporulate, it was evident that cells expressing mutations I111K, Q113A, Q116A, and F115A did not differ from wild-type cells ([Table 3](#T3){ref-type="table"}). However, L125D and Q113L L125D, and F115A L125D expressing cells did not sporulate. These results, together with the yeast two-hybrid and immunoprecipitation experiments, suggest that the putative syntaxin N-peptide--binding area in Sec1p domain 1 is involved in Mso1p binding.

###### 

Sporulation of *sec1* mutants

  Mutant        Sporulation
  ------------- -------------
  WT            \+
  R9A           \+
  S39K          \+
  V55D          −
  D56A          \+
  I111K         \+
  Q113A         \+
  F115A         \+
  Q116A         \+
  L125D         −
  Q113A L125D   −
  F115L L125D   −

Mutations L25D and V55D in Sec1p Affect SNARE Complex Binding
-------------------------------------------------------------

We next studied the role of the second potential protein interaction interface in domain 1 for Mso1p binding. A set of mutations were generated in this area. Mutations S39K and D56A target amino acids that, based on the structural data, are expected to face the SNARE complex ([Figure 4](#F4){ref-type="fig"}, A, B, and D). In addition, a mutation in the neighboring residue V55D was introduced. Furthermore, we generated the L25D mutation, which is in a less conserved region further away from the syntaxin interaction pocket ([Figure 4](#F4){ref-type="fig"}D). Previously, a mutation affecting the same position (W28) in Munc18-1 was shown to participate in syntaxin 1 binding ([@B34]). In addition, a mutation R9A, located at the "saddle-point" between the syntaxin and the putative N-peptide binding areas, was generated ([Figure 4](#F4){ref-type="fig"}B).

In the yeast two-hybrid assay a slight decrease in Mso1p interaction was observed for Sec1p(V55D), whereas no effect for other mutants tested was seen ([Figure 6](#F6){ref-type="fig"}A). To address the functionality of the different *sec1* mutants in vivo, we created a strain where *MSO1* is HA tagged and the *sec1* mutants were the only copy of Sec1p expressed. The *sec1* (L25D) strain was not viable. This suggests that, based on homology with the Munc18 W28 ([@B34]; [@B7]), Sec1p L25D is likely to face Sso proteins and may therefore significantly affect Sec1p--SNARE complex interaction. The mutations V55D and D56A affect the same potential binding surface ([Figure 4](#F4){ref-type="fig"}D). However, only Sec1p (V55D) showed reduced binding to Mso1p in the yeast two-hybrid assay and rendered the strain temperature sensitive ([Figure 6](#F6){ref-type="fig"}A; Supplementary Figure S5A). When *MSO1* was deleted from this strain, an increase in the temperature sensitivity in the *sec1(V55D)* strain was observed. At the same time, the wild-type and other *sec1* mutant strains remained the same (Supplementary Figure S5B). When *MSO1* was overexpressed in *sec1(V55D)* cells, a full rescue of the temperature-sensitive phenotype was observed (Supplementary Figure S5C). This suggests that Mso1p interaction with the N-peptide binding area is important for the functional stabilization of Sec1p (V55D).

![SNARE complex, but not Mso1p binding is affected in *sec1* (L25D) and *sec1* (V55D) mutants. (A) Yeast two-hybrid assay between Mso1p and different Sec1p syntaxin-binding mutants. As a negative control Bicoid (B1228) and as a positive control Gal4 (B1229) was used. The interactions were scored of two 10-fold dilutions on medium lacking leucine. In B and C less coimmunoprecipitation of Sso1p/2p and Sec9p is observed in Sec1p- (V55D) and Sec1p- (D56A) expressing cells. *MSO1-HA* cells expressing different *sec1* mutants were grown until a OD~600~ = 1, lysed, and subjected to anti-HA immunoprecipitations. Immunoprecipitates were analyzed by Western blotting, and the blots detected with anti-HA, Sec1p, Sso1p/2p, and Sec9 antibodies. (B) A representative Western blot of the immunoprecipitations. (C) Quantification of independent immunoprecipitations, normalized to the amount of immunoprecipitated Mso1p-HA. SDs are shown for each immunoprecipitation. (D) Localization of the Mso1p interaction site with Sec1p mutants L25D, V55D, and D56A in vivo. Haploid, vegetatively grown cells (H304) expressing YFP(C)-Mso1p (B3044) and different mutant versions of Sec1p-Venus(N) \[wt (B2930), L25D (B3260), V55D (B3261), and D56A (B3262)\] were investigated by fluorescence microscopy. (E) Sec1p(L25D) BiFC interaction with Sso1p and Sso2p is sensitive to deletion of *MSO1*. Haploid vegetatively grown cells \[wt (H304) or Δ*mso1* (H2658)\] expressing Sec1p-YFP(C) wt (B3308) or the L25D (B3312) mutant together with either YFP(N)-Sso1p (B3307) or YFP(N)-Sso2p (B3309) were investigated by fluorescence microscopy for YFP signal. The BiFC signal was quantified as described in *Materials and Methods.*.](zmk0081094150006){#F6}

When V55D and D56A mutant cell lysates were subjected to immunoprecipitations, the Mso1p-HA levels immunoprecipitated were similar ([Figure 6](#F6){ref-type="fig"}, B and C). Compared with wild-type lysates, Mso1p-HA immunoprecipitations from *sec1(D56A)* strain lysates showed marginal changes in the amount of coprecipitating Sec1p (87 ± 18%), Sso1p/2p (94 ± 14%), and Sec9p (90 ± 20%; [Figure 6](#F6){ref-type="fig"}, B and C). In V55D lysates, no significant change for coimmunoprecipitation of Sec1p (98 ± 27%) with Mso1p was observed. However, a drop in coimmunoprecipitation for Sso1p/2p (65 ± 19%, 35% less) and Sec9p (52 ± 25%, 48% less) was observed ([Figure 6](#F6){ref-type="fig"}, B and C). Considering that the Sec1p interaction with the SNAREs is essential, it is plausible that the significantly reduced binding of Sec1p (V55D) with Sso1p/2p and Sec9p accounts for the temperature-sensitivity of the *sec1* (V55D) strain.

To analyze Mso1p interactions with the syntaxin binding surface mutants, cells were transformed with plasmids expressing YFP(C)-Mso1p, together with wild-type or the mutant versions L25D, V55D, or D56A of Sec1-Venus(N). In line with the immunoprecipitation results, Mso1p--Sec1p interaction was detected by BiFC at the bud tip growing bud and the septum of dividing cells ([Figure 6](#F6){ref-type="fig"}D). The characteristic daughter cell plasma membrane--associated BiFC signal for Mso1p--Sec1p interaction was reduced in V55D expressing cells and was almost undetectable in L25D mutant cells. At the same time, a 12--33% increase in the cytoplasm signal was detected in these mutants ([Figure 6](#F6){ref-type="fig"}D), suggesting that while Mso1p--Sec1p complexes are not disrupted, they are less membrane associated.

Based on the structural data, the L25D mutation is likely to be important for Sec1p interaction with syntaxins ([@B34]). To address the observed positive effect of Mso1p on Sec1p mutants, we analyzed the BiFC signal between Sec1p (L25D) and Sso1p and Sso2p in wild-type and Δ*mso1* cells. When *sec1(L25D)* was expressed in wild-type cells together with Sso1p or Sso2p, compared with wt Sec1p--Ssop signal, a 50% lower BiFC signal was detected at the plasma membrane on average ([Figure 6](#F6){ref-type="fig"}E). When the same interaction was measured in Δ*mso1* cells, an additional 25% drop in the plasma membrane signal intensity was observed ([Figure 6](#F6){ref-type="fig"}E). These data suggests that Mso1p can provide additional affinity and stability for Sec1p--Sso1p/Sso2p binding.

Mso1p Can Interact with Sso Proteins
------------------------------------

The role of the putative domain 1 N-peptide--binding area in Mso1p interaction and the stabilizing effect of Mso1p on Sec1p-Ssop interaction prompted us to analyze whether Mso1p can associate with Sso1p and Sso2p. To test this, interaction of Mso1p with the cytosolic domains of Sso1p and Sso2p was first analyzed by the yeast two-hybrid assay. Interaction between Mso1p(38-210) and Sso1p, and repeatedly slightly less with Sso2p, was observed ([Figure 7](#F7){ref-type="fig"}A). No interaction was detected between Mso1p and the cytosolic domains of v-SNAREs Snc1p or Snc2p ([Figure 7](#F7){ref-type="fig"}A). The interaction between the Sec1p-binding deficient Mso1p(59-210) mutant and Sso proteins persisted, whereas reduced interaction was observed for Mso1p(136-210) (Supplementary Figure S6A). Deletion of the Mso1p C-terminus up to amino acid 94 did not reduce binding with Sso proteins. This suggests that amino acids 59-94 contain a motif that can interact with Sso1p and Sso2p in the yeast two-hybrid assay.

![Mso1p interacts with Sso1p and Sso2p. (A) Yeast two-hybrid assay between Mso1p and Sso1p, Sso2p, Snc1p, and Snc2p. As negative control Bicoid (B1228) and as positive control Gal4 (B1229) was used. Two 10-fold dilutions on medium with or without leucine are shown. (B) In vitro analysis of Sso protein interaction with Mso1p. The interactions were analyzed by the surface plasmon resonance technique as described in *Materials and Methods.* (C) Mso1p interacts with Sso1p/2p at the plasma membrane. Haploid vegetatively grown cells expressing YFP(C)-Mso1p (B3044), YFP(C)-Mso1p(1-58) (B3355), YFP(C)-Mso1p(1-135) (B3354), YFP(C)-Mso1p(136-210) (B3043), and YFP(N)-Sso1p/2p (B3307, B3309) were investigated by fluorescence microscopy. (D) Quantification of the Mso1p--Ssop localization. (E) Quantification of the Mso1p-Ssop plasma membrane signal intensity in daughter versus mother cell.](zmk0081094150007){#F7}

We next used surface plasmon resonance technique to test for possible direct interactions between Mso1p and Sso proteins in vitro. For this, His~6~-tagged Mso1p was expressed in E. coli, purified, and coupled to a sensor chip. The cytosolic fragments of untagged Sso1p and Sso2p were then flown on top of the immobilized Mso1p, and binding of Sso proteins with Mso1p was recorded. For 6.5 μM Sso1p weak binding with Mso1p was observed ([Figure 7](#F7){ref-type="fig"}B; Supplementary Figure 6B). Under the same conditions, no binding for Sso2p with Mso1p was observed in this assay.

To analyze the interactions of Mso1p with Sso1p and Sso2p in vivo, we made use of the BiFC assay. When full-length Mso1p or Mso1p(1-135) was expressed, a BiFC signal was observed at the plasma membrane for Sso1p and Sso2p binding ([Figure 7](#F7){ref-type="fig"}C). No signal was observed for Mso1p(1-58) and Mso1p(136-210) interaction with Ssos ([Figure 7](#F7){ref-type="fig"}C). This result is in line with the yeast two-hybrid data, suggesting that Mso1p amino acids 59 to 94 contribute to Sso interaction (Supplementary Figure S6). Interestingly, the Mso1p(1-210)--Sso1p BiFC signal was consistently stronger at the daughter cell plasma membrane ([Figure 7](#F7){ref-type="fig"}, C and D). At the same time, the signal for Mso1p--Sso2p interaction was stronger at the mother cell plasma membrane and weaker at the daughter cell plasma membrane ([Figure 7](#F7){ref-type="fig"}, C and D). Quantification of the BiFC signal in these cells revealed that compared with Mso1p--Sso2p, Mso1p--Sso1p BiFC complexes displayed more than twofold enrichment in the daughter cells ([Figure 7](#F7){ref-type="fig"}E).

DISCUSSION
==========

Members of the SM protein family are central regulators of membrane fusion ([@B25]; [@B50]). Several SM family members bind a N-terminal peptide of syntaxins ([@B24]; [@B36]). However, the role of the N-peptide binding in SM or SNARE protein complex regulation is currently unclear. Recent results indicate that the N-peptide is needed for neurotransmission in C. elegans ([@B28]). However, abolishment of the N-terminal peptide binding between Sly1p-Sed5p and Vps45p-Tlg2p does not result in any obvious in vivo phenotypes in yeast ([@B41]; [@B8]). In contrast to syntaxin1, Sed5p or Tlg2p, yeast syntaxins Sso1p and Sso2p do not have a N-terminal peptide for Sec1p binding and are thus likely to be regulated in a different way.

We previously identified Mso1p as a Sec1p-binding protein and showed that it is required for membrane fusion ([@B1]; [@B31]). In the present study, we show that Mso1p and Sec1p interact at the plasma membrane of the growing daughter cell and at the septum of dividing cells. This interaction site fits with the previously published localization of GFP-tagged forms of Mso1p and Sec1p ([@B9]; [@B31]). The localization of Mso1p--Sec1p complexes at the plasma membrane was sensitive to inactivation of Sec4p ([Figure 1](#F1){ref-type="fig"}D). This finding is in line with the results showing that in *sec4* mutant cell lysates, Mso1p--Sec1p complexes are stable, but they do not interact with plasma membrane--associated SNARE complex subunits ([@B31]).

Our results show that Sec1p domain 1 is important for Mso1p binding in vivo. The combined use of yeast two-hybrid, BiFC, immunoprecipitation, and genetic techniques show that mutations in the putative N-peptide binding area in Sec1p domain 1 affect Mso1p--Sec1p interaction. In addition, our results show that domain 1 mutations affecting Mso1p interaction lead to inhibition of prospore membrane formation ([Table 2](#T2){ref-type="table"}). Mso1p binding to Sec1p is essential for the homotypic fusion of prospore membrane precursor vesicles ([@B31]). The sporulation inhibition by the N-peptide--binding area mutations suggests an important role for this interaction surface in Ssop-Sncp-Sec9p complex--mediated membrane fusion.

The minimal Mso1p peptide that can mediate Sec1p interaction, both in vivo and in vitro ([@B31]) does not display obvious sequence similarity with the syntaxin N-peptides. An interesting target for future studies will be to reveal how closely Mso1p binding with the domain 1 resembles the binding modes of the syntaxin N-terminal peptides. To resolve this matter, the three-dimensional structure of Mso1p--Sec1p complexes needs to be determined.

Genetic results suggest a stabilizing role for Mso1p in Sec1p--SNARE complex binding. This idea is supported by the capability of *MSO1* overexpression to rescue the temperature-sensitive phenotype of the Sso binding--deficient *sec1* (V55D) mutant. A similar stabilizing role was revealed by the significantly reduced BiFC signal between the syntaxin-binding--deficient Sec1p(L25D) and Sso proteins at the plasma membrane when Mso1p was deleted ([Figure 6](#F6){ref-type="fig"}E). The capability of Mso1p to facilitate the function of the syntaxin binding--deficient Sec1p mutants could be explained by its association with Sso proteins. Such an interaction is supported by several lines of evidence. Mso1p was shown by the yeast two-hybrid technique to interact with Sso proteins. In vitro analysis of Mso1p--Ssop interaction revealed a weak interaction between Sso1p and Mso1p. No interaction with Sso2p was detected in vitro. Yeast exocytosis involves Sec1p binding with an assembled SNARE complex composed of Sso1p/2p-Sec9p-Snc1p/2p ([@B9]; [@B44]; [@B49]; [@B21]). Our data indicates that the Mso1p--Ssop interaction takes place within a larger protein complex in vivo ([@B31]; [Figure 5](#F5){ref-type="fig"}). Because of insufficient folding or affinity, weak interactions between the subunits of a larger protein complex may be challenging to reproduce in vitro without the stabilizing contribution of other subunits. Similarly to Mso1p--Ssop binding, the in vitro interaction between isolated Sec1p and Sso proteins is weak ([@B44]; [@B49]). Point mutations in Sec1p domain 1 did not result in complete loss of coimmunoprecipitation of Sec1p and Sso proteins with Mso1p ([Figure 5](#F5){ref-type="fig"}, B and C). It is possible that the reason for this coimmunoprecipitation is at least partly explained by the affinity of Mso1p to Sso proteins.

A difference in Mso1p interaction with Sso1p and Sso2p is in line with the yeast two-hybrid data, where repeatedly, a weaker interaction between Mso1p and Sso2p was observed ([Figure 7](#F7){ref-type="fig"}B). In addition, previous data indicate a difference in the functional association between Mso1p and Sso1p or Sso2p. Although *MSO1* deletion in *sso2-1* cells causes a synthetic phenotype even in the presence of the wt *SSO1*, no effect is observed for the viability of *sso1-1 SSO2* cells deleted for *MSO1* ([@B27]). This suggests that Mso1p is important for full Sso1p functionality when the paralogous Sso2p is functionally compromised. At the same time, the opposite seems not to be the case ([@B27]). A difference in the functional association between Mso1p and Sso proteins is further supported by the cooperation of Mso1p with Sso1p, but not with Sso2p in membrane fusion of prospore membrane precursor vesicles in meiotic diploid cells ([@B27]; [@B31]).

The BiFC analysis indicated that amino acids 59-94 are important for Mso1p interaction with Sso proteins at the plasma membrane in vivo. Negligible interaction signal was detected for Mso1p(1-58) and Mso1p(136-210) with Sso1p or Sso2p ([Figure 7](#F7){ref-type="fig"}C). However, the Mso1p(1-58) was clearly targeted to the plasma membrane, as an interaction between that fragment and Sec1p was readily visualized at the plasma membrane by BiFC ([Figure 1](#F1){ref-type="fig"}A). Taking into account that Sso proteins are plasma membrane bound, our results show that a mere plasma membrane colocalization is not sufficient for the Mso1--Ssop BiFC signal. Interestingly, BiFC analysis revealed a qualitatively different distribution for Mso1p--Sso1p and Mso1p--Sso2p complexes. Mso1p--Sso1p complexes occupied predominantly the daughter cell plasma membrane, whereas Mso1p--Sso2p complexes were enriched in the mother cell. These findings support the selectivity of Mso1p interactions with Sso1p and Sso2p containing SNARE complexes.

In the present study, for the first time, protein interaction sites for the exocytic machinery are reported. Our results suggest that in vegetatively growing haploid cells there is a preference for association of Mso1p with Sso1p containing SNARE complexes at the fast growing daughter cell plasma membrane, rather than in the more quiescent mother cell. This type of differences would be impossible to detect by biochemical techniques analyzing protein-protein interactions in cell lysates. This underscores the usefulness of techniques like BiFC that enable spatial resolution of protein interactions sites.

SM protein interactions with SNARE complexes and syntaxins have received significant attention during the least 10 years. At the same time the binding modes of known SM protein interactors outside the SNARE protein family are largely uncharacterized. The present work is the first detailed analysis of interactions between a SM protein with its non-SNARE--binding partner. Our results suggest that Mso1p can act as a bridging factor between Sec1p domain 1 and Sso proteins and possibly, through this interaction, can stabilize Sec1p--SNARE complexes. The binding of the N-peptide with SM proteins is not essential in vegetatively grown haploid cells ([@B41]; [@B8]). Likewise, Mso1p--Sec1p interaction is nonessential for haploid cell viability. However, Mso1p binding with the domain 1 appears to be essential for homotypic membrane fusion of prospore membrane precursor vesicles in diploid cells. Membrane fusion initiation of these precursor vesicles, docked to the spindle pole body, is triggered during meiosis by a poorly characterized, temporally regulated signal ([@B35]). It is interesting to note, that this signal triggered membrane fusion may bear similarities with fusion of neurotransmitter loaded, docked vesicles at the presynaptic membrane. Syntaxin N-peptide binding with UNC-18 appears to be important for neurotransmission in C. elegans ([@B28]). In case of Sso proteins, which do not possess such a peptide, Mso1p could mimic this role and therefore be essential for membrane fusion in meiotic cells. It appears, that constitutive exocytosis during haploid cell growth does not require such tight regulation by Mso1p.

Mso1p is homologous with the PTB-binding domains of the Munc18-binding Mint proteins ([@B31]). The functional role of Mint proteins in association with Munc18 is poorly understood. However, Mint proteins have been proposed to act as adaptors interlinking several proteins involved in neuronal exocytosis ([@B2]). Our results suggest a similar role for Mso1p in the regulation of Sec1p and SNARE complexes. We propose that Mso1p acts as a facilitator of Sec1p function through its interactions with Sec1p and Sso proteins to ensure efficient membrane fusion.
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